Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
1.070
+0.499 (87.36%)
At close: Feb 3, 2026, 4:00 PM EST
1.270
+0.200 (18.69%)
After-hours: Feb 3, 2026, 6:49 PM EST
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $28.96 million as of February 3, 2026. Its market cap has decreased by -61.66% in one year.
Market Cap
28.96M
Enterprise Value
29.68M
1-Year Change
-61.66%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $28.96M, a decrease of -91.63%. That is a compound annual growth rate of -41.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 15.46M | -6.38% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 16.74M |
| Traws Pharma | 16.30M |
| Quantum BioPharma | 16.01M |
| Citius Pharmaceuticals | 15.77M |
| Applied Therapeutics | 15.70M |
| Cadrenal Therapeutics | 15.62M |
| KALA BIO | 14.90M |
| OSR Holdings | 14.35M |